In Vivo Monitoring of Pancreatic β-Cells in a Transgenic Mouse Model

We generated a transgenic mouse model ( RIP-luc ) for the in vivo monitoring of pancreatic islet mass and function in response to metabolic disease. Using the rat insulin promoter fused to firefly luciferase, and noninvasive technology to detect luciferase activity, we tracked changes in reporter si...

Full description

Saved in:
Bibliographic Details
Main Authors: Steven J. Smith, Hongbing Zhang, Anne O. Clermont, Alvin C. Powers, Dixon B. Kaufman, Anthony F. Purchio, David B. West
Format: Article
Language:English
Published: SAGE Publishing 2006-04-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2006.00007
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841564527025455104
author Steven J. Smith
Hongbing Zhang
Anne O. Clermont
Alvin C. Powers
Dixon B. Kaufman
Anthony F. Purchio
David B. West
author_facet Steven J. Smith
Hongbing Zhang
Anne O. Clermont
Alvin C. Powers
Dixon B. Kaufman
Anthony F. Purchio
David B. West
author_sort Steven J. Smith
collection DOAJ
description We generated a transgenic mouse model ( RIP-luc ) for the in vivo monitoring of pancreatic islet mass and function in response to metabolic disease. Using the rat insulin promoter fused to firefly luciferase, and noninvasive technology to detect luciferase activity, we tracked changes in reporter signal during metabolic disease states and correlated the changes in luciferase signal with metabolic status of the mouse. Transgene expression was found to be specific to the pancreatic islets in this transgenic model. Basal transgene expression was tracked in male and female mice fed either a chow or a high-fat diet and in response to treatment with streptozotocin. Pancreatic bioluminescent signal increased in mice fed a high-fat diet compared with chow-fed animals. In a model of chemically induced diabetes, the bioluminescent signal decreased in accordance with the onset of diabetes and reduction of islet β-cell number. Preliminary studies using islets transplanted from this transgenic model suggest that in vivo image analysis can also be used to monitor transplanted islet viability and survival in the host. This transgenic model is a useful tool for in vivo studies of pancreatic β-cells and as a donor for islet transplantation studies.
format Article
id doaj-art-32f35fa541764f56b887df62fe16bffe
institution Kabale University
issn 1536-0121
language English
publishDate 2006-04-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-32f35fa541764f56b887df62fe16bffe2025-01-02T22:37:59ZengSAGE PublishingMolecular Imaging1536-01212006-04-01510.2310/7290.2006.0000710.2310_7290.2006.00007In Vivo Monitoring of Pancreatic β-Cells in a Transgenic Mouse ModelSteven J. Smith0Hongbing Zhang1Anne O. Clermont2Alvin C. Powers3Dixon B. Kaufman4Anthony F. Purchio5David B. West6Xenogen Corporation, Alameda, CAXenogen Corporation, Alameda, CAXenogen Corporation, Alameda, CAVA Tennessee Valley Healthcare SystemNorthwestern University, ChicagoXenogen Corporation, Alameda, CAXenogen Corporation, Alameda, CAWe generated a transgenic mouse model ( RIP-luc ) for the in vivo monitoring of pancreatic islet mass and function in response to metabolic disease. Using the rat insulin promoter fused to firefly luciferase, and noninvasive technology to detect luciferase activity, we tracked changes in reporter signal during metabolic disease states and correlated the changes in luciferase signal with metabolic status of the mouse. Transgene expression was found to be specific to the pancreatic islets in this transgenic model. Basal transgene expression was tracked in male and female mice fed either a chow or a high-fat diet and in response to treatment with streptozotocin. Pancreatic bioluminescent signal increased in mice fed a high-fat diet compared with chow-fed animals. In a model of chemically induced diabetes, the bioluminescent signal decreased in accordance with the onset of diabetes and reduction of islet β-cell number. Preliminary studies using islets transplanted from this transgenic model suggest that in vivo image analysis can also be used to monitor transplanted islet viability and survival in the host. This transgenic model is a useful tool for in vivo studies of pancreatic β-cells and as a donor for islet transplantation studies.https://doi.org/10.2310/7290.2006.00007
spellingShingle Steven J. Smith
Hongbing Zhang
Anne O. Clermont
Alvin C. Powers
Dixon B. Kaufman
Anthony F. Purchio
David B. West
In Vivo Monitoring of Pancreatic β-Cells in a Transgenic Mouse Model
Molecular Imaging
title In Vivo Monitoring of Pancreatic β-Cells in a Transgenic Mouse Model
title_full In Vivo Monitoring of Pancreatic β-Cells in a Transgenic Mouse Model
title_fullStr In Vivo Monitoring of Pancreatic β-Cells in a Transgenic Mouse Model
title_full_unstemmed In Vivo Monitoring of Pancreatic β-Cells in a Transgenic Mouse Model
title_short In Vivo Monitoring of Pancreatic β-Cells in a Transgenic Mouse Model
title_sort in vivo monitoring of pancreatic β cells in a transgenic mouse model
url https://doi.org/10.2310/7290.2006.00007
work_keys_str_mv AT stevenjsmith invivomonitoringofpancreaticbcellsinatransgenicmousemodel
AT hongbingzhang invivomonitoringofpancreaticbcellsinatransgenicmousemodel
AT anneoclermont invivomonitoringofpancreaticbcellsinatransgenicmousemodel
AT alvincpowers invivomonitoringofpancreaticbcellsinatransgenicmousemodel
AT dixonbkaufman invivomonitoringofpancreaticbcellsinatransgenicmousemodel
AT anthonyfpurchio invivomonitoringofpancreaticbcellsinatransgenicmousemodel
AT davidbwest invivomonitoringofpancreaticbcellsinatransgenicmousemodel